Nasal Vaccination Against SARS-CoV-2: Synergistic or Alternative to Intramuscular Vaccines?

Mattia Tiboni, Luca Casettari, Lisbeth Illum

It is striking that all marketed SARS-CoV-2 vaccines are developed for intramuscular administration designed to produce humoral and cell mediated immune responses, preventing viremia and the COVID-19 syndrome. They have a high degree of efficacy in humans (70–95%) depending on the type of vaccine. However, little protection is provided against viral replication and shedding in the upper airways due to the lack of a local sIgA immune response, indicating a risk of transmission of virus from vaccinated individuals.

A range of novel nasal COVID-19 vaccines are in development and preclinical results in non-human primates have shown a promising prevention of replication and shedding of virus due to the induction of mucosal immune response (sIgA) in upper and lower respiratory tracts as well as robust systemic and humoral immune responses. Whether these results will translate to humans remains to be clarified. An IM prime followed by an IN booster vaccination would likely result in a better well-rounded immune response, including prevention (or strong reduction) in viral replication in the upper and lower respiratory tracts.

Latest articles

Carla Burns Many brands of menstrual pads and disposable diapers contain elevated...
Canadian Biotechnology Action Network With this controversial reform proposal, the seed industry...
David Bell The Lancet recently released its long-awaited COVID-19 commission report. The report well...
Euzebiusz Jamrozik The global response to the recent coronavirus pandemic has revealed...
Abdulrahman Koshak et al. Effective treatment for patients with the novel Coronavirus...
James A. Thorp et al. Objectives: Assess rates of adverse events (AE)...

Your donation helps us
stand up for health freedom!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Thank you!

The form has been submitted successfully!